Skip to main content
. Author manuscript; available in PMC: 2016 Nov 17.
Published in final edited form as: Circulation. 2015 Oct 19;132(20):1863–1870. doi: 10.1161/CIRCULATIONAHA.114.014694

Table 3.

Hemodynamic Characteristics of Patients Experiencing and Not Experiencing an Adverse Event.

Major Adverse Event
No. (%) (N =19,608; SV=3,775) Yes (n=378; SV=102) No (n= 19,230; SV=3,673) P value
Systemic Ventricular EDP-- mean± s.d.* 10.8 ± 4.9 11.5 ± 6.1 10.8 ± 4.9 0.04
Cardiac Index-- mean± s.d. 3.8 ± 1.3 3.7 ± 1.4 3.8 ± 1.3 0.11
Single Ventricle Hemodynamic Data
    Systemic Saturation-- mean± s.d. 83.3 ± 10.3 76.5 ± 16.1 83.5 ± 10.0 <0.001
    Mixed Venous Saturation-- mean± s.d.§ 61.3 ± 11.2 54.1 ± 13.9 61.5 ± 11.0 < 0.001
    MPA Mean Pressure -- mean± s.d. 16.0 ± 7.4 19.0 ± 8.7 15.9 ± 7.3 < 0.001
Non-Single Ventricle Hemodynamic Data
    Systemic Saturation-- mean± s.d.# 94.7 ± 7.1 92.4 ± 10.5 94.7 ± 7.0 < 0.001
    Mixed Venous Saturation-- mean± s.d.** 70.3 ± 9.4 65.3 ± 13.6 70.3 ± 9.3 < 0.001
    MPA Systolic Pressure -- mean± s.d.*** 31.5 ± 16.7 38.1 ± 22.6 31.4 ± 16.6 < 0.001
Systemic Ventricular EDP ≥ 18mmHg 0.005
    Yes-- no. (%) 988 ( 5.0) 27 (7.1) 961 (5.0)
    No-- no. (%) 11,332 (57.8) 189 (50.0) 11,143 (57.9)
    Missing-- no. (%) 7,288 (37.2) 162 (42.9) 7,126 (37.1)
Saturation <95% (non-SV) or <78% (SV) <0.001
    Yes-- no. (%) 4,894 (25.0) 128 (33.9) 4,766 (24.8)
    No-- no. (%) 12,765 (65.1) 191 (50.5) 12,574 (65.4)
    Missing-- no. (%) 1,949 (9.9) 59 (15.6) 1,890 (9.8)
MV Saturation <60% (non-SV) or <50% (SV)
    Yes-- no. (%) 2,131 (10.9) 90 (23.8) 2,041 (10.6) <0.001
    No-- no. (%) 14,856 (75.8) 210 (55.6) 14,646 (76.2)
    Missing-- no. (%) 2,621 (13.4) 78 (20.6) 2,543 (13.2)
PA Systolic Pressure ≥45 (non-SV) or Mean Pressure ≥17mmHg (SV) <0.001
    Yes-- no. (%) 2.933 (15.0) 85 (22.5) 2.848 (14.8)
    No-- no. (%) 13.046 (66.5) 171 (45.2) 12.875 (67.0)
    Missing-- no. (%) 3.629 (18.5) 122 (32.3) 3.507 (18.2)

Abbreviations: no., number; s.d, standard deviation; SV, single ventricle; EDP, end diastolic pressure; MPA, main pulmonary artery; PA, pulmonary artery

*

7, 288 patients (162 with and 7,126 without adverse events) with missing information for systemic ventricular EDP

4,179 patients (134 with and 4,045 without adverse events) with missing information for cardiac index

301 patients (15 with and 286 without adverse events) with missing information for SV systemic saturation

§

476 patients (23 with and 453 without adverse events) with missing information for SV mixed venous saturation

811 patients (31 with and 780 without adverse events) with missing information for SV MPA mean pressure

#

1.648patients (44 with and 1604 without adverse events) with missing information for non-SV systemic saturation

**

2.145 patients (55 with and 2.090 without adverse events) with missing information for non-SV mixed venous saturation

***

2.818 patients (91 with and 2.727 without adverse events) with missing information for non-SV MPA systolic pressure